BMC Nephrology

official impact factor 2.14

Open Access Highly Access Study protocol

A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]

Ronald J Hogg*, Robert J Wyatt and Scientific Planning Committee of the North American IgA Nephropathy Study

BMC Nephrology 2004, 5:3 doi:10.1186/1471-2369-5-3

No comments have yet been made on this article.

Post a comment